ACB Stock Analysis: Buy, Sell, or Hold?
ACB - Aurora Cannabis Inc. Common Shares
$3.25
-0.07 (-2.26%)
▼
5d:
-5.12%
30d:
-11.34%
90d:
-9.86%
HOLD
LOW Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: Jun 17, 2026
29d
Get Alerted When ACB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called ACB this week
67% bullish • 1 bearish
67% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ACB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ACB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: ACB is currently trading at $3.25, which is considered oversold relative to its 30-day fair value range of $3.33 to $3.60. From a valuation perspective, the stock is trading at a discount (Forward PE: -63.9) compared to its historical average (43.0). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, ACB is in a strong downtrend. The price is currently testing key support at $3.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ACB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.34 (+91.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ACB is in a strong downtrend. The price is currently testing key support at $3.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ACB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.34 (+91.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.33 -
$3.60
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.4%
Protect Your Profits
Holding ACB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 91.1% below Wall St target ($6.34)
- CAUTION: Recommendation downgraded due to -5.1% 5-day decline
Trading Range Analysis
30-Day Trading Range
$3.33 -
$3.60
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.31
(9.7%)
Support & Resistance Levels
Support Level
$3.23
Resistance Level
$3.56
Current Trend
Strong Downtrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-63.85
Wall Street Target
$6.34
(+91.1%)
Revenue Growth (YoY)
6.8%
Earnings Growth (YoY)
-94.7%
Profit Margin
-22.5%
PE vs Historical
-63.9 vs 43.0
CHEAP
Share & Embed Analysis
Last updated: May 18, 2026 2:40 PM ET
Data refreshes hourly during market hours. Next update: 3:40 PM
Data refreshes hourly during market hours. Next update: 3:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$191 | 55 HOLD |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$131 | 54 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 60 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 58 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$40 | 58 HOLD |
Advanced ACB Option Strategies
Professional options setups generated by AI based on today's ACB price and gamma walls.
